3Weiss R, D'Adamo E, Santoro N, et al. Basal a-cell up-regula- tion in obese insulin-resistant adolescents. J Clin Endocrirtol Metab, 2011,96 : 91-97.
4Guardado-Mendoza R, Jimenez-Ceja L, Majluf-Cruz A, et al. Impact of obesity severity and duration on pancreatic β-and α-cell dy- namics in normoglycemic non-human primates. Int J Obcs (Lond) ,2013,37:1071-1078.
5Henquin JC, Rahier J. Pancreatic alpha cell mass in European subjects with type 2 diabetes. Diabetologia, 2011, 54: 1720-1725.
6Dal S, Jeandidier N, Seyfritz E, et al. Featured Article: Oxidative stress status and liver tissue defenses in diabetic rats during inten- sive subcutaneous insulin therapy[J]. Exp Biol Med (Maywood), 2016,241 (2): 184 - 192.
7Cetinkalp S, Felekoglu C, Karadeniz M, et al. Comparison of the effects of intensive insulin treatment modalities on cardiovascular biomarkers in type 1 diabetes mellitus[J]. Diabetes Metab Syndr, 2015,9(3): 157 - 162.
8Deeb A, Abu - Awad S, Abood S, et al. Important determinants of diabetes control in insulin pump therapy in patients with type 1 diabetes mellitus[J]. Diabetes Technol Ther, 2015, 17(3): 166 - 170.
9Malik FS, Taplin CE. Insulin therapy in children and adolescents with type 1 diabetes[J]. Paediatr Drugs,2014,16(2): 141 - 150.
